Cardiol Therapeutics (CRDL) Accounts Payables: 2021
- Cardiol Therapeutics' Accounts Payables was N/A to $3.9 million in Q4 2021 from the same period last year, while for Dec 2021 it was $3.9 million, marking a year-over-year change of. This contributed to the annual value of $3.9 million for FY2021, which is N/A change from last year.
- Latest data reveals that Cardiol Therapeutics reported Accounts Payables of $3.9 million as of Q4 2021.
- In the past 5 years, Cardiol Therapeutics' Accounts Payables ranged from a high of $3.9 million in Q4 2021 and a low of $3.9 million during Q4 2021.
- In the last 1 years, Cardiol Therapeutics' Accounts Payables had a median value of $3.9 million in 2021 and averaged $3.9 million.
